hsa-miR-363-3p

ncRNA information

ncRNA name

hsa-miR-363-3p

Specific or universal ncRNAs

Specific ncRNAs

Class

MicroRNA

Biomarker

No

Biomarker application

Upstream regulatory factors

Not available

Downstream target

CUL4A

Cancer information

Cancer name

Non-Small Cell Lung Cancer

Cancer site

Lung

Treatment information

Treatment type

Chemotherapy

Drug

Gemcitabine

Impact of wild-type ncRNA on chemotherapy resistance

Down

Impact of knockdown of ncRNA on chemotherapy resistance

Impact of overexpression of ncRNA on chemotherapy resistance

Clinical Information

ncRNA differential expression in
cancer patients vs. healthy people

Not available

Number of patients

Not available

Male patients

Not available

Female patients

Not available

Age range and number

Not available

Research information

PMID

Description

The results indicated that decreased miR-363-3p expression enhanced gemcitabine resistance in NSCLC cells via regulation of CUL4A.

Tissue resource

tumor tissues and matched adjacent normal tissues were collected from non-small cell lung cancer patients

human lung epithelial cell lines BEAS-2B

human non-small cell lung cancer cell lines A549

human non-small cell lung cancer cell lines H23

Experiment

qRT-PCR,Western blot,Luciferase reporter assay


Institute

the Yancheng City No.1 People's Hospital

American Type Culture Collection

Country

China

USA

Continent

Asia

North American